6TWU image
Deposition Date 2020-01-13
Release Date 2020-04-01
Last Version Date 2024-01-24
Entry Detail
PDB ID:
6TWU
Title:
MAGI1_2 complexed with a phosphomimetic 16E6 peptide
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.40 Å
R-Value Free:
0.25
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 2 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1,Annexin A2
Gene (Uniprot):ANXA2, MAGI1
Chain IDs:A, B
Chain Length:427
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Protein E6
Gene (Uniprot):E6
Chain IDs:C
Chain Length:10
Number of Molecules:1
Biological Source:Human papillomavirus type 16
Primary Citation
Dual Specificity PDZ- and 14-3-3-Binding Motifs: A Structural and Interactomics Study.
Structure 28 747 759.e3 (2020)
PMID: 32294469 DOI: 10.1016/j.str.2020.03.010

Abstact

Protein-protein interaction motifs are often alterable by post-translational modifications. For example, 19% of predicted human PDZ domain-binding motifs (PBMs) have been experimentally proven to be phosphorylated, and up to 82% are theoretically phosphorylatable. Phosphorylation of PBMs may drastically rewire their interactomes, by altering their affinities for PDZ domains and 14-3-3 proteins. The effect of phosphorylation is often analyzed by performing "phosphomimetic" mutations. Here, we focused on the PBMs of HPV16-E6 viral oncoprotein and human RSK1 kinase. We measured the binding affinities of native, phosphorylated, and phosphomimetic variants of both PBMs toward the 266 human PDZ domains. We co-crystallized all the motif variants with a selected PDZ domain to characterize the structural consequence of the different modifications. Finally, we elucidated the structural basis of PBM capture by 14-3-3 proteins. This study provides novel atomic and interactomic insights into phosphorylatable dual specificity motifs and the differential effects of phosphorylation and phosphomimetic approaches.

Legend

Protein

Chemical

Disease

Primary Citation of related structures